149 related articles for article (PubMed ID: 9314981)
1. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt.
Nazarian GK; Bjarnason H; Dietz CA; Bernadas CA; Foshager MC; Ferral H; Hunter DW
Radiology; 1997 Oct; 205(1):173-80. PubMed ID: 9314981
[TBL] [Abstract][Full Text] [Related]
2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
3. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
4. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
6. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
9. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
10. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
Harrod-Kim P; Saad WE; Waldman D
J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
13. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
Nair S; Singh R; Yoselewitz M
J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
[TBL] [Abstract][Full Text] [Related]
14. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
[TBL] [Abstract][Full Text] [Related]
15. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment.
Crenshaw WB; Gordon FD; McEniff NJ; Perry LJ; Hartnell G; Anastopoulos H; Jenkins RL; Lewis WD; Wheeler HG; Clouse ME
Radiology; 1996 Jul; 200(1):185-92. PubMed ID: 8657908
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of refractory ascites using a transjugular intrahepatic portosystemic shunt (TIPS). Clinical case].
Zapata R; Fava M
Rev Med Chil; 1999 Oct; 127(10):1229-35. PubMed ID: 10835740
[TBL] [Abstract][Full Text] [Related]
17. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts.
Bercu ZL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Schiano TD; Chang CY; Lookstein RA
AJR Am J Roentgenol; 2015 Mar; 204(3):654-61. PubMed ID: 25714299
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites.
Williams DB; Waugh R; Selby W
Aust N Z J Med; 1998 Oct; 28(5):620-6. PubMed ID: 9847951
[TBL] [Abstract][Full Text] [Related]
19. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
